The Latest Cardiac and Vascular News
VANCOUVER, Jan. 28, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today the Executive Steering Committee for […]
Soin brings extensive pain treatment and clinical experience to the JanOne team with particular expertise in pain associated with cardiovascular conditions LAS VEGAS, Jan. 28, 2020 /PRNewswire/ — JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with nonaddictive […]
IRVINE, Calif., Jan. 28, 2020 /PRNewswire/ — Inari Medical, Inc., a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the appointment of Cynthia Lucchese and Catherine Szyman to the company’s Board of Directors. “We are pleased to welcome Cindy and Katie as new […]
Desert Medical Imaging to become HALO Dx Center of Innovation MENLO PARK, Calif., Jan. 30, 2020 /PRNewswire/ — HALO Dx, Inc., a rapid growth technology company headquartered in Silicon Valley, has brought together top technology experts with leading radiologists to set the new standard of care for the industry. By leveraging leading-edge artificial […]
NASDAQ: CORV TSX: CORV VANCOUVER, Jan. 28, 2020 /PRNewswire/ – Correvio Pharma Corp. (Nasdaq: CORV) (TSX: CORV), (“Correvio” or the “Company”) announced today that it has received two written notifications from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price and the minimum market […]
LONDON and MONTREAL, Jan. 27, 2020 (GLOBE NEWSWIRE) — DalCor Pharmaceuticals today announced that following the results of the interim futility analysis of the dalcetrapib dal-GenE Phase 3 trial, DalCor will continue the dal-GenE trial as recommended by the independent Data and Safety Monitoring Board (DSMB). “We are pleased to […]
Former Mayo Clinic Physician Administrator Joins to Drive Collaboration between Physicians, Clinical Research, and the Continued Development of Life-Improving Technology LAKE OSWEGO, Ore., Jan. 27, 2020 /PRNewswire/ — BIOTRONIK, Inc. today announced the appointment of David Hayes, MD, FACC, as Chief Medical Officer. Dr. Hayes will oversee the development of BIOTRONIK’s cardiovascular solutions with a […]
MINNEAPOLIS–(BUSINESS WIRE)–Imricor Medical Systems, Inc. (ASX:IMR) today announces that it has received CE mark approval for its Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode. This follows earlier CE mark approval for Imricor to place its Advantage-MR EP Recorder/Stimulator System on the market in Europe. Imricor is the first and only company […]
One year ago, we received our first 510(k) clearance for ECG for Verily Study Watch — a wrist-worn, sensor-based device for non-invasive, continuous monitoring. Today, we’re thrilled to share that we’ve received a new 510(k) clearance for Study Watch with Irregular Pulse Monitor. This validates our approach at Verily to building robust, clinical […]
VANCOUVER, Jan. 24, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that after further successful acute […]
